These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2559413)

  • 1. Comparison of the effect of lipoxygenase metabolites of arachidonic acid and eicosapentaenoic acid on human natural killer cell cytotoxicity.
    Chang KJ; Saito H; Tatsuno I; Tamura Y; Watanabe K; Yoshida S
    Prostaglandins Leukot Essent Fatty Acids; 1989 Nov; 38(2):87-90. PubMed ID: 2559413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid.
    Heidel JR; Taylor SM; Laegreid WW; Silflow RM; Liggitt HD; Leid RW
    Am J Pathol; 1989 Mar; 134(3):671-6. PubMed ID: 2538061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 5-lipoxygenase products of arachidonic acid in cell-to-cell interaction between macrophages and natural killer cells in rat spleen.
    Chang KJ; Saito H; Tatsuno I; Tamura Y; Yoshida S
    J Leukoc Biol; 1991 Sep; 50(3):273-8. PubMed ID: 1906918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect between leukotriene B4 and leukotriene B5 on the induction of interleukin 1-like activity and calcium mobilizing activity in human blood monocytes.
    Tatsuno I; Saito H; Chang KJ; Tamura Y; Yoshida S
    Agents Actions; 1990 Mar; 29(3-4):324-7. PubMed ID: 2160190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of lipoxygenase metabolites of eicosapentaenoic acid by bovine alveolar macrophages in vitro.
    Laegreid WW; Taylor SM; Silflow RM; Straub KM; Breeze RG; Liggitt HD; Leid RW
    Inflammation; 1988 Oct; 12(5):503-14. PubMed ID: 2848771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral ingestion of eicosapentaenoic acid-ethyl ester on natural killer cell activity in rat spleen cells.
    Chang KJ; Saito H; Tamura Y; Watanabe K; Yoshida S
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):31-5. PubMed ID: 2548219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Products of the lipoxygenase pathway in human natural killer cell cytotoxicity.
    Rossi P; Lindgren JA; Kullman C; Jondal M
    Cell Immunol; 1985 Jun; 93(1):1-8. PubMed ID: 2986854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipoxygenation in human natural killer cell activation.
    Bray RA; Brahmi Z
    J Immunol; 1986 Mar; 136(5):1783-90. PubMed ID: 3081633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
    Lee TH; Menica-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Biol Chem; 1984 Feb; 259(4):2383-9. PubMed ID: 6321468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary oils on the production of n-3 and n-6 metabolites of leukocyte 5-lipoxygenase in five rat strains.
    Cleland LG; James MJ; Gibson RA; Hawkes JS; Betts WH
    Biochim Biophys Acta; 1990 Apr; 1043(3):253-8. PubMed ID: 2157490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic and eicosapentaenoic acid metabolism in bovine neutrophils and platelets: effect of calcium ionophore.
    Taylor SM; Laegreid WW; Heidel JR; Straub KM; Liggitt HD; Silflow RM; Breeze RG; Leid RW
    J Leukoc Biol; 1987 Sep; 42(3):253-62. PubMed ID: 3040877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipoxygenase pathway in the human NK cell system.
    Jondal M; Kullman C; Lindgren JA; Rossi P
    Adv Exp Med Biol; 1985; 184():257-70. PubMed ID: 2994411
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of orally administered eicosapentaenoic acid (EPA) on the formation of leukotriene B4 and leukotriene B5 by rat leukocytes.
    Terano T; Salmon JA; Moncada S
    Biochem Pharmacol; 1984 Oct; 33(19):3071-6. PubMed ID: 6091668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid.
    Takenaga M; Hirai A; Terano T; Tamura Y; Kitagawa H; Yoshida S
    Thromb Res; 1986 Feb; 41(3):373-84. PubMed ID: 3010490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by leukotriene B5 of leukotriene B4-induced activation of human keratinocytes and neutrophils.
    Kragballe K; Voorhees JJ; Goetzl EJ
    J Invest Dermatol; 1987 May; 88(5):555-8. PubMed ID: 2437212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of plasma levels of biologically active leukotriene B compounds during anaphylaxis in guinea pigs pretreated by indomethacin or by a fish oil-enriched diet.
    Lee TH; Israel E; Drazen JM; Leitch AG; Ravalese J; Corey EJ; Robinson DR; Lewis RA; Austen KF
    J Immunol; 1986 Apr; 136(7):2575-82. PubMed ID: 3005414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human natural killer cell activity by (14R,15S)-14,15-dihydroxy-5Z,8Z,10E,12E- icosatetraenoic acid.
    Ramstedt U; Serhan CN; Lundberg U; Wigzell H; Samuelsson B
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):6914-8. PubMed ID: 6095260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells.
    Cifone MG; Botti D; Festuccia C; Napolitano T; del Grosso E; Cavallo G; Chessa MA; Santoni A
    Cell Immunol; 1993 May; 148(2):247-58. PubMed ID: 8388321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible inhibition of lymphokine-activated killer cell activity by lipoxygenase-pathway inhibitors.
    Sibbitt WL; Imir T; Bankhurst AD
    Int J Cancer; 1986 Oct; 38(4):517-21. PubMed ID: 3019899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.